PCSK9 inhibitors and diabetes risk: a question worth asking?: Table 1

A question worth asking?

Sex Differences in Hypertension: A Question worth Asking?

Sex Differences in Hypertension: A Question worth Asking? Mario Lombardi1, Paolo Severi2, Andrea Mazza3, Maria Grazia Bendini3, Elisa Caldarone1, Massimo Armeni4, Stefania D’Emidio1 and Massimo Leggio2* 1Physical Medicine and Neurorehabilitation Operative Unit, Salus Infi rmorum Clinic, Rome, Italy 2Department of Medicine and Rehabilitation, Cardiac Rehabilitation Operative Unit, San Filippo Ne...

Knowledge and question asking.

The ability and the motivation for question asking are, or should be, some of the most important aims of education. Unfortunately, students neither ask many questions, nor good ones. The present paper is about the capacity of secondary school pupils for asking questions and how this activity depends on prior knowledge. To examine this, we use texts containing different levels of information abo...

PCSK9 Inhibitors

Alirocumab and evolocumab are monoclonal antibodies that block proprotein convertase subtilisin/kexin type 9 (PCSK9), a circulating protein that degrades low-density lipoprotein (LDL) receptors. These therapies increase LDL receptors on the cell surface and reduce plasma LDL cholesterol. Both therapies are approved to lower LDL cholesterol, a causative agent for atherosclerotic cardiovascular d...

Asking the right question: Risk and expectation in multiagent contracting

In this paper we are interested in the decision problem faced by an agent when requesting bids for collections of tasks with complex time constraints and interdependencies. In particular, we study the problem of specifying an appropriate schedule for the tasks in the request for bids. We expect bids to require resource commitments, so we expect different setting of time windows to solicit diffe...